Blue Owl Capital Holdings »

Roadzen shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Roadzen (RDZNW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Roadzen

Tip: Access up to 7 years of quarterly data

All positions including Roadzen held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roadzen by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $20k 225k 0.09

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Roadzen

Highbridge Capital Management
Polar Securities
Calamos Advisors
Saba Capital Management
Shaolin Capital Management
Verition Fund Management
Wolverine Asset Management
Goldman Sachs Group
Blue Owl Capital Holdings
Atalaya Capital Management
Davidson Kempner Capital Management
D. E. Shaw & Co
Q Global Advisors
Zazove Associates
MMCAP International Inc. SPC

View all funds holding Roadzen